Evidence map›Paper›PMID 40018213›Full record

ArticleBMJ public health2024

Evaluating and mapping the evidence that screening for diabetic foot disease meets the criteria for population-wide screening: a scoping review.

Jennifer A Pallin, Lauren Connell, Caroline McIntosh, Paul Kavanagh, Sean F Dinneen, Patricia M Kearney, Claire M Buckley

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jennifer A PallinSchool of Public Health, University College Cork, Cork, Ireland.ORCID 0000-0003-1434-6152
Lauren ConnellHealth Promotion Research Centre (HPRC), University of Galway, Galway, Ireland.
Caroline McIntoshDepartment of Podiatric Medicine, University of Galway, Galway, Ireland.
Paul KavanaghHealth Intelligence Unit, Strategic Planning and Transformation, Health Service Executive, Dublin, Ireland.
Sean F DinneenCenter for Endocrinology, Diabetes and Metabolism, Galway University Hospitals, Galway, Ireland.
Patricia M KearneySchool of Public Health, University College Cork, Cork, Ireland.
Claire M BuckleySchool of Public Health, University College Cork, Cork, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate and map the evidence around diabetes-related foot screening using the World Health Organisation screening principles, which set the gold standard for determining the appropriateness of introducing population-wide screening programmes internationally. Design: A scoping review methodology in line with Arksey and O'Malley and the Joanna Briggs Institute. Data sources: Medline (EBSCO), Scopus, ScienceDirect and EMBASE between 24 May 2022 and 12 July 2022. Reference lists of the selected studies, and 'Google' and 'Google Scholar' were also searched. Eligibility criteria: Inclusion criteria were informed by the principles of screening. Articles, published in English since 2000, reporting on the impact of the diabetes-related foot ulcers, effectiveness of treatment available for those identified as being at risk, reliability of screening tests for screening for the at-risk foot and the effectiveness, cost-effectiveness, safety and ethics of diabetes-related foot screening programmes were included. Data extraction and synthesis: Data were extracted by one reviewer, with data extraction headings relating to the principles of screening. A narrative synthesis approach was used to report the information from included studies. Results: 46 articles were deemed eligible for inclusion. Diabetes-related foot ulcers are an important health condition associated with increased risk of mortality and poorer quality of life. However, there is insufficient evidence on the effectiveness of treatments to prevent disease development. Moreover, while consensus exists on what screening tools should be used to screen for risk factors, there is no agreement on threshold values. Finally, there is no available information on the potential budgetary, organisational or societal implications of a whole-population diabetes-related foot screening programme. Conclusion: Existing evidence does not support the introduction of an organised population-wide screening programme in the context of World Health Organisation screening principles. Further research on treatment and management strategies for the at-risk foot and of whole-population screening programmes is required.

Indexed as

Community HealthMass ScreeningPopulation SurveillancePreventive MedicinePrimary Prevention

Identifiers

PMID40018213
PMCPMC11812814

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.